Filament Health Corp (FH) — Strategic Asset Allocation Index
Filament Health Corp (FH) has a Strategic Asset Allocation Index of 150.5% as of March 2025. Strategic assets (PP&E of CA$- plus long-term investments of CA$1.47 Million) total CA$1.47 Million, measured against net assets of CA$974.38K. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Filament Health Corp balance sheet independence to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Filament Health Corp Strategic Asset Allocation Index (2021–2024)
This chart shows how Filament Health Corp's Strategic Asset Allocation Index has evolved across 4 annual periods from 2021 to 2024. As of March 2025, the index stands at 150.5%, representing strategic assets of CA$1.47 Million against net assets of CA$974.38K CAD. For live market cap and overall valuation, see FH market cap overview.
Annual Strategic Asset Allocation Index for Filament Health Corp (2021–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Filament Health Corp from 2021 to 2024, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Filament Health Corp (FH) shareholders funds for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CAD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 86.6% | CA$1.51 Million | CA$- | CA$1.51 Million | CA$1.75 Million | ▲ +28.4 pp |
| 2023 | 58.2% | CA$1.45 Million | CA$- | CA$1.45 Million | CA$2.49 Million | ▲ +58.2 pp |
| 2022 | 0.0% | CA$0.00 | CA$- | CA$0.00 | CA$3.19 Million | ▼ -7.1 pp |
| 2021 | 7.1% | CA$1.18 Million | CA$1.18 Million | CA$- | CA$16.55 Million | — |